Monitoring of patients with heart failure

Scandinavian Journal of Clinical and Laboratory Investigation, Supplement

Volumn 65, Issue 240, 2005, Pages 99-106

  Mair, Johannes ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

B type natriuretic peptide (BNP); N terminal pro B type natriuretic peptide (NT proBNP)

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; UNCLASSIFIED DRUG; PEPTIDE FRAGMENT; PRO BRAIN NATRIURETIC PEPTIDE (1 76); PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ACCURACY; ACUTE HEART FAILURE; BLOOD SAMPLING; CLINICAL FEATURE; CONFERENCE PAPER; DISEASE COURSE; FEASIBILITY STUDY; HEART FAILURE; IN VITRO STUDY; LABORATORY TEST; MEDICAL SOCIETY; MORTALITY; PATHOPHYSIOLOGY; PATIENT MONITORING; PRACTICE GUIDELINE; PRIORITY JOURNAL; STANDARDIZATION; BLOOD; CONGESTIVE HEART FAILURE; HUMAN; REVIEW; CORRELATION ANALYSIS; DATA ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; EVALUATION; EXERCISE; REST; SAFETY;

HEART FAILURE, CONGESTIVE; HUMANS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS;

EID: 23744470673     PISSN: 0085591X     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365510500236234     Document Type: Conference Paper

References (29)

1. Mair J, Hammerer-Lercher A, Puschendorf B. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure. Clin Chem Lab Med 2001;39:571-88.
2. Hartman F, Packer M, Coats AJS, Fowler MB, Krum H, Mohasci P, Rouleau JL, Tendera M, Castaigne A, Trawinski J. NT-proBNP in severe chronic heart failure: rationale, design, and preliminary results of the COPERNICUS NT-proBNP substudy. Eur J Heart Fail 2004;6:343-50.
3. Yu CM, Sanderson JE. Plasma brain natriuretic peptide - an independent predictor of cardiovascular mortality in acute heart failure. Eur J Heart Fail 1999;1:59-65.
4. Packer M. Should B-type natriuretic peptide be measured routinely to guide the diagnosis and management of chronic heart failure? Circulation 2003;108:2950-3.
5. Nieminen MS, Böhm M, Cowie MR, Drexler H, Filippatos GS, Jondeau G, Hasin Y, Lopez-Sendon J, Mebazaa A, Metra M, Rhodes A, Swedberg K. for the Task Force on Acute Heart Failure of the European Society of Cardiology. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure. Eur Heart J 2005;26:384-416.
6. Remme WJ and Swedberg K for the European Society of Cardiology Task Force for the Diagnosis and Treatment of Chronic Heart Failure. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001;22:1527-60.
7. Fraser CG. Inherent biological variation and reference values. Clin Chem Lab Med 2004;42:758-64.
8. Latini R, Masson S, Anand I, Salio M, Hester A, Judd D, Barlera S, Maggioni AP, Tognoni G, Cohn JN. The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT. Eur Heart J 2004;25:292-9.
9. Luchner A, Hengstenberg C, Löwel H, Trawinski J, Baumann M, Riegger GAJ, Schunkert H, Holmer S. N-terminal pro-brain natriuretic peptide after myocardial infarction - A marker of cardio-renal dysfunction. Hypertension 2002;39:99-104.
10. McCullough PA, Due P, Omland T, Mc Cord J, Nowak RM, Hollander JE. BNP and renal function in the diagnosis of heart failure: an analysis from the breathing not properly multinational study. Am J Kidney Dis 2003;41:571-9.
11. Wang TJ, Larson MG, Levy D, Emelia B, Leip E, Wilson P, Vasan RS. Impact of obesity on plasma natriuretic peptide levels. Circulation 2004;109:594-600.
12. Mehra MR, Uber PA, Park MH, Scott RL, Ventura HD, Harris BC, Frohlich ED. Obesity and suppressed BNP levels in heart failure. J Am Coll Cardiol 2004;43:1590-5.
13. Levin ER, Gardner DG, Samson WK. Natriuretic Peptides (review). New Engl J Med 1998;339:321-8.
14. Sothern RB, Vesely DL, Kanabrocki EL, Bremner FW, Third JL, McCormick JB, Dawson S, Ryan M. Circadian relationships between circulating atrial natriuretic peptides and serum sodium and chloride in healthy humans. Am J Nephrol 1996;16:462-70.
15. Wu AHB, Packer M, Smith A, Bijou R, Fink D, Mair J, Wallentin L, Johnston N, Feldcamp CS, Haverstick DM, Ahnardi CE, Grant A, Despres N, Bluestein B, Ghani F. Analytical and clinical evaluation of the Bayer ADVIA Centaur automated B-type natriuretic peptide assay in patients with heart failure: a multisite study. Clin Chem 2004;50:867-73.
16. Yeo KTJ, Wu AHB, Apple FS, Kroll MH, Christenson RH, Lewandrowski KB, Sedor FA, Butch AW. Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay. Clin Chim Acta 2003;338:107-115.
17. Jensen KT, Carsens J, Ivarsen P, Pedersen EB. A new fast and reliable radioimmunoassay of brain natriuretic peptide in human plasma. Reference values in healthy subjects and in patients with different diseases. Scand J Clin Lab Invest 1997;57:529-40.
18. Sayama H, Nakamura Y, Saito N, Kinoshita M. Why is the concentration of plasma brain natriuretic peptide in elderly inpatients greater than normal? Coron Artery Dis 1999;10:537-40.
19. Maffei S, Clerico A, Iervasi G, Nannipieri M, Del Ry S, Giannessi D, Donato L. Circulating levels of cardiac natriuretic hormones measured in women during menstrual cycle. J Endocrinol Invest 1999;22:1-5.
20. Rutherford AJ, Anderson JV, Elder MG, Bloom SR. Release of atrial natriuretic peptide during pregnancy and immediate puerperium. Lancet 1987;1:928-9.
21. Nelzi dEril, GV, Tagnochetti T, Nauti A, Klersy C, Papalia A, Vadacca G, Moratti R, Merlini G. Biological variation of NT-proBNP in healthy individuals. Clin Chem 2003;49:1554-5.
22. Wu AHB, Smith A, Wieczorek S, Mather JF, Duncan B, White M, McGill C, Katten D, Heller G. Biologic variation for N-terminal pro and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure. Am J Cardiol 2003;92:628-31.
23. Bruins S, Fokkema MR, Römer JWP, DeJongste MJL, van der Dijs FPL, van den Ouweland JMW, Muskiet FAJ. High intraindividual variation of BNP and NT-proBNP in patients with stable chronic heart failure. Clin Chem 2004;50:2052-8.
24. Hammerer-Lercher A, Pölzl G, Falkensammer G, Ludwig W, Hügel H, Pachinger O, Puschendorf B, Mair J. B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide are comparably useful for disease monitoring in heart failure. Int J Cardiol 2005 (in press).
25. Anand IS, Fisher LD, Chiang YT, Latini R, Masson S, Maggioni AP, Glazer RD, Tognoni G, Cohn JN. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsertan Heart Failure Trial (Val-HeFT). Circulation 2003;107:1278-83.
26. Friedl W, Mair J, Thomas S, Pichler M, Puschendorf B. Natriuretic peptides and cyclic guanosine 3′5′-monophosphate in asymptomatic and symptomatic left ventricular dysfunction. Heart 1996;76:129-36.
27. Krüger S, Graf J, Merx MW, Stickel T, Kunz D, Hanrath P, Janssens U. Brain natriuretic peptide kinetics during dynamic exercise in patients with chronic heart failure. Int J Cardiol 2004;95:49-54.
28. Herrmann M, Scharhag J, Miclea M, Urhausen A, Herrmann W, Kindermann W. Post-race kinetics of cardiac troponin T and I and NT-proBNP in marathon runners. Clin Chem 2003;49:831-4.
29. Boomsma F, Deinum J, van den Meiracker AH. Relationship between natriuretic peptide concentrations in plasma and posture during blood sampling. Clin Chem 2001;47:963-5.